COVID-19 Updates
From the Journals
A new long COVID explanation: Low serotonin levels?
The study found lower serotonin levels in long COVID patients, compared with patients who were diagnosed with acute COVID-19 but who fully...
Feature
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.
Practice Alert
Keep COVID-19 vaccination on your patients’ radar
Waning vaccine-induced immunity and viral mutation require updated COVID-19 interventions. Here’s the latest on vaccines and immunization...
From the Journals
People with long COVID don’t show signs of brain damage
“The findings thus suggest that post-COVID condition is not the result of ongoing infection, immune activation, or brain damage.”
News from the FDA/CDC
FDA to health care providers: Double-check COVID vaccine dose for children
“Parents were telling us of cases where pharmacies accidentally gave their children a double dose, while doctors in our group were pointing out...
From the Journals
Serious mental illness tied to 50% higher all-cause mortality risk after COVID
“From a public health perspective, our study has emphasized the need for early and timely preventative interventions (e.g. vaccination) for the...
From the Journals
Nirmatrelvir-ritonavir ineffective at reducing most post-COVID conditions
However, thromboembolic events were reduced.
News
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...
From the Journals
Vaccination status doesn’t impact infectivity timeline in kids
”Current policies requiring isolation for 5 days after a positive test might be appropriate, as the majority of children were not infectious by...
From the Journals
COVID, no matter the severity, linked with urologic effects in men
“Clinicians should be aware of the significantly higher incidence of [lower urinary tract infection] complications with COVID-19 in this patient...
From the Journals
Paxlovid tied to benefits in high-risk patients with COVID
No significant benefit was observed in patients who were not immunocompromised.